Phase II study of recombinant human interferon gamma for treatment of cutaneous T-cell lymphoma.

Source:http://linkedlifedata.com/resource/pubmed/id/2104937

J. Natl. Cancer Inst. 1990 Feb 7 82 3 208-12

Download in:

View as

Triples

General Info

PMID
2104937